Clinical Trials
The Netherlands-based company Prosena has begun the submission process...
The news is a remarkable turnaround for the drug, which had looked doomed to failure just a few months ago. In January this year, GlaxoSmithKline...
Clinical Trials
Oramed recruits patients to study orally ingestible insulin capsule
Oramed Pharmaceuticals has started recruiting patients for a new clinical trial of ORMD-0801, an orally ingestible insulin capsule, for patients with type 1 diabetes mellitus...
Clinical Trials
DiaMedica completes enrollment in DM199 single ascending dose diabetes...
Clinical stage biopharmaceutical company DiaMedica has completed enrollment of type 2 diabetic patients in the DM199 single ascending dose (SAD) clinical study. ...
Clinical Trials
Eli Lilly reports positive data from Phase III study...
Eli Lilly and Company has reported positive data from the Phase III study of Cialis/finasteride in men with lower urinary tract symptoms of benign...
Clinical Trials
Diffusion completes enrolling brain cancer patients in TSC Phase...
Diffusion Pharmaceuticals has completed enrolling 56 patients with newly diagnosed primary brain cancer (glioblastoma multiforme or GBM) in the Phase II trial of an...
Clinical Trials
Boston Therapeutics presents PAZ320 drug positive Phase ll results
Boston Therapeutics has presented positive results of its PAZ320 drug, designed for reducing post-meal elevation of blood glucose, from its Phase ll clinical trial....
Clinical Trials
Avaxia treats first patient in ulcerative colitis drug study
Avaxia Biologics has treated the first patient in a Phase1b clinical study using AVX drug dosage, designed for the treatment of ulcerative colitis. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.